Clinical Trial Update: Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors [Phase 2]

View source ↗

Summary

This Phase 2 trial update evaluates pemetrexed response in metastatic urothelial bladder cancer and other solid tumors based on tumor gene alterations, and is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma of the Bladder

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Northwestern University | Conditions: Metastatic Bladder Urothelial Carcinoma, Metastatic Malignant Solid Neoplasm | Phase 2 | Status: RECRUITING